451
|
Aaij R, Abellán Beteta C, Adeva B, Adinolfi M, Affolder A, Ajaltouni Z, Akar S, Albrecht J, Alessio F, Alexander M, Ali S, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amerio S, Amhis Y, An L, Anderlini L, Andreassi G, Andreotti M, Andrews JE, Appleby RB, Aquines Gutierrez O, Archilli F, d'Argent P, Artamonov A, Artuso M, Aslanides E, Auriemma G, Baalouch M, Bachmann S, Back JJ, Badalov A, Baesso C, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Batozskaya V, Battista V, Bay A, Beaucourt L, Beddow J, Bedeschi F, Bediaga I, Bel LJ, Bellee V, Belloli N, Belyaev I, Ben-Haim E, Bencivenni G, Benson S, Benton J, Berezhnoy A, Bernet R, Bertolin A, Bettler MO, van Beuzekom M, Bifani S, Billoir P, Bird T, Birnkraut A, Bizzeti A, Blake T, Blanc F, Blouw J, Blusk S, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borisyak M, Borsato M, Bowcock TJV, Bowen E, Bozzi C, Braun S, Britsch M, Britton T, Brodzicka J, Brook NH, Buchanan E, Burr C, Bursche A, Buytaert J, Cadeddu S, Calabrese R, Calvi M, Calvo Gomez M, Campana P, Campora Perez D, Capriotti L, Carbone A, Carboni G, Cardinale R, Cardini A, Carniti P, Carson L, Carvalho Akiba K, Casse G, Cassina L, Castillo Garcia L, Cattaneo M, Cauet C, Cavallero G, Cenci R, Charles M, Charpentier P, Chatzikonstantinidis G, Chefdeville M, Chen S, Cheung SF, Chiapolini N, Chrzaszcz M, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coco V, Cogan J, Cogneras E, Cogoni V, Cojocariu L, Collazuol G, Collins P, Comerma-Montells A, Contu A, Cook A, Coombes M, Coquereau S, Corti G, Corvo M, Couturier B, Cowan GA, Craik DC, Crocombe A, Cruz Torres M, Cunliffe S, Currie R, D'Ambrosio C, Dall'Occo E, Dalseno J, David PNY, Davis A, De Aguiar Francisco O, De Bruyn K, De Capua S, De Cian M, De Miranda JM, De Paula L, De Simone P, Dean CT, Decamp D, Deckenhoff M, Del Buono L, Déléage N, Demmer M, Derkach D, Deschamps O, Dettori F, Dey B, Di Canto A, Di Ruscio F, Dijkstra H, Donleavy S, Dordei F, Dorigo M, Dosil Suárez A, Dovbnya A, Dreimanis K, Dufour L, Dujany G, Dungs K, Durante P, Dzhelyadin R, Dziurda A, Dzyuba A, Easo S, Egede U, Egorychev V, Eidelman S, Eisenhardt S, Eitschberger U, Ekelhof R, Eklund L, El Rifai I, Elsasser C, Ely S, Esen S, Evans HM, Evans T, Falabella A, Färber C, Farley N, Farry S, Fay R, Ferguson D, Fernandez Albor V, Ferrari F, Ferreira Rodrigues F, Ferro-Luzzi M, Filippov S, Fiore M, Fiorini M, Firlej M, Fitzpatrick C, Fiutowski T, Fleuret F, Fohl K, Fol P, Fontana M, Fontanelli F, Forshaw DC, Forty R, Frank M, Frei C, Frosini M, Fu J, Furfaro E, Gallas Torreira A, Galli D, Gallorini S, Gambetta S, Gandelman M, Gandini P, Gao Y, García Pardiñas J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauld R, Gavardi L, Gazzoni G, Gerick D, Gersabeck E, Gersabeck M, Gershon T, Ghez P, Gianì S, Gibson V, Girard OG, Giubega L, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gotti C, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graverini E, Graziani G, Grecu A, Greening E, Griffith P, Grillo L, Grünberg O, Gui B, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haines SC, Hall S, Hamilton B, Han X, Hansmann-Menzemer S, Harnew N, Harnew ST, Harrison J, He J, Head T, Heijne V, Heister A, Hennessy K, Henrard P, Henry L, Hernando Morata JA, van Herwijnen E, Heß M, Hicheur A, Hill D, Hoballah M, Hombach C, Hulsbergen W, Humair T, Hushchyn M, Hussain N, Hutchcroft D, Hynds D, Idzik M, Ilten P, Jacobsson R, Jaeger A, Jalocha J, Jans E, Jawahery A, John M, Johnson D, Jones CR, Joram C, Jost B, Jurik N, Kandybei S, Kanso W, Karacson M, Karbach TM, Karodia S, Kecke M, Kelsey M, Kenyon IR, Kenzie M, Ketel T, Khairullin E, Khanji B, Khurewathanakul C, Kirn T, Klaver S, Klimaszewski K, Kochebina O, Kolpin M, Komarov I, Koopman RF, Koppenburg P, Kozeiha M, Kravchuk L, Kreplin K, Kreps M, Krokovny P, Kruse F, Krzemien W, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kuonen AK, Kurek K, Kvaratskheliya T, Lacarrere D, Lafferty G, Lai A, Lambert D, Lanfranchi G, Langenbruch C, Langhans B, Latham T, Lazzeroni C, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Lemos Cid E, Leroy O, Lesiak T, Leverington B, Li Y, Likhomanenko T, Liles M, Lindner R, Linn C, Lionetto F, Liu B, Liu X, Loh D, Longstaff I, Lopes JH, Lucchesi D, Lucio Martinez M, Luo H, Lupato A, Luppi E, Lupton O, Lusardi N, Lusiani A, Machefert F, Maciuc F, Maev O, Maguire K, Malde S, Malinin A, Manca G, Mancinelli G, Manning P, Mapelli A, Maratas J, Marchand JF, Marconi U, Marin Benito C, Marino P, Marks J, Martellotti G, Martin M, Martinelli M, Martinez Santos D, Martinez Vidal F, Martins Tostes D, Massacrier LM, Massafferri A, Matev R, Mathad A, Mathe Z, Matteuzzi C, Mauri A, Maurin B, Mazurov A, McCann M, McCarthy J, McNab A, McNulty R, Meadows B, Meier F, Meissner M, Melnychuk D, Merk M, Michielin E, Milanes DA, Minard MN, Mitzel DS, Molina Rodriguez J, Monroy IA, Monteil S, Morandin M, Morawski P, Mordà A, Morello MJ, Moron J, Morris AB, Mountain R, Muheim F, Müller D, Müller J, Müller K, Müller V, Mussini M, Muster B, Naik P, Nakada T, Nandakumar R, Nandi A, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neuner M, Nguyen AD, Nguyen TD, Nguyen-Mau C, Niess V, Niet R, Nikitin N, Nikodem T, Novoselov A, O'Hanlon DP, Oblakowska-Mucha A, Obraztsov V, Ogilvy S, Okhrimenko O, Oldeman R, Onderwater CJG, Osorio Rodrigues B, Otalora Goicochea JM, Otto A, Owen P, Oyanguren A, Palano A, Palombo F, Palutan M, Panman J, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parker W, Parkes C, Passaleva G, Patel GD, Patel M, Patrignani C, Pearce A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perret P, Pescatore L, Petridis K, Petrolini A, Petruzzo M, Picatoste Olloqui E, Pietrzyk B, Pikies M, Pinci D, Pistone A, Piucci A, Playfer S, Plo Casasus M, Poikela T, Polci F, Poluektov A, Polyakov I, Polycarpo E, Popov A, Popov D, Popovici B, Potterat C, Price E, Price JD, Prisciandaro J, Pritchard A, Prouve C, Pugatch V, Puig Navarro A, Punzi G, Qian W, Quagliani R, Rachwal B, Rademacker JH, Rama M, Ramos Pernas M, Rangel MS, Raniuk I, Rauschmayr N, Raven G, Redi F, Reichert S, Dos Reis AC, Renaudin V, Ricciardi S, Richards S, Rihl M, Rinnert K, Rives Molina V, Robbe P, Rodrigues AB, Rodrigues E, Rodriguez Lopez JA, Rodriguez Perez P, Roiser S, Romanovsky V, Romero Vidal A, Ronayne JW, Rotondo M, Ruf T, Ruiz Valls P, Saborido Silva JJ, Sagidova N, Saitta B, Salustino Guimaraes V, Sanchez Mayordomo C, Sanmartin Sedes B, Santacesaria R, Santamarina Rios C, Santimaria M, Santovetti E, Sarti A, Satriano C, Satta A, Saunders DM, Savrina D, Schael S, Schiller M, Schindler H, Schlupp M, Schmelling M, Schmelzer T, Schmidt B, Schneider O, Schopper A, Schubiger M, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Semennikov A, Serra N, Serrano J, Sestini L, Seyfert P, Shapkin M, Shapoval I, Shcheglov Y, Shears T, Shekhtman L, Shevchenko V, Shires A, Siddi BG, Silva Coutinho R, Silva de Oliveira L, Simi G, Sirendi M, Skidmore N, Skwarnicki T, Smith E, Smith E, Smith IT, Smith J, Smith M, Snoek H, Sokoloff MD, Soler FJP, Soomro F, Souza D, Souza De Paula B, Spaan B, Spradlin P, Sridharan S, Stagni F, Stahl M, Stahl S, Stefkova S, Steinkamp O, Stenyakin O, Stevenson S, Stoica S, Stone S, Storaci B, Stracka S, Straticiuc M, Straumann U, Sun L, Sutcliffe W, Swientek K, Swientek S, Syropoulos V, Szczekowski M, Szumlak T, T'Jampens S, Tayduganov A, Tekampe T, Tellarini G, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Todd J, Tolk S, Tomassetti L, Tonelli D, Topp-Joergensen S, Torr N, Tournefier E, Tourneur S, Trabelsi K, Traill M, Tran MT, Tresch M, Trisovic A, Tsaregorodtsev A, Tsopelas P, Tuning N, Ukleja A, Ustyuzhanin A, Uwer U, Vacca C, Vagnoni V, Valenti G, Vallier A, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, van Veghel M, Velthuis JJ, Veltri M, Veneziano G, Vesterinen M, Viaud B, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Volkov V, Vollhardt A, Voong D, Vorobyev A, Vorobyev V, Voß C, de Vries JA, Waldi R, Wallace C, Wallace R, Walsh J, Wang J, Ward DR, Watson NK, Websdale D, Weiden A, Whitehead M, Wicht J, Wilkinson G, Wilkinson M, Williams M, Williams MP, Williams M, Williams T, Wilson FF, Wimberley J, Wishahi J, Wislicki W, Witek M, Wormser G, Wotton SA, Wraight K, Wright S, Wyllie K, Xie Y, Xu Z, Yang Z, Yu J, Yuan X, Yushchenko O, Zangoli M, Zavertyaev M, Zhang L, Zhang Y, Zhelezov A, Zhokhov A, Zhong L, Zhukov V, Zucchelli S. Observation of B_{s}^{0}→D[over ¯]^{0}K_{S}^{0} and Evidence for B_{s}^{0}→D[over ¯]^{*}^{0}K_{S}^{0} Decays. PHYSICAL REVIEW LETTERS 2016; 116:161802. [PMID: 27152791 DOI: 10.1103/physrevlett.116.161802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2016] [Indexed: 06/05/2023]
Abstract
The first observation of the B_{s}^{0}→D[over ¯]^{0}K_{S}^{0} decay mode and evidence for the B_{s}^{0}→D[over ¯]^{*0}K_{S}^{0} decay mode are reported. The data sample corresponds to an integrated luminosity of 3.0 fb^{-1} collected in pp collisions by LHCb at center-of-mass energies of 7 and 8 TeV. The branching fractions are measured to be B(B_{s}^{0}→D[over ¯]^{0}K[over ¯]^{0})=[4.3±0.5(stat)±0.3(syst)±0.3(frag)±0.6(norm)]×10^{-4},B(B_{s}^{0}→D[over ¯]^{*0}K[over ¯]^{0})=[2.8±1.0(stat)±0.3(syst)±0.2(frag)±0.4(norm)]×10^{-4},where the uncertainties are due to contributions coming from statistical precision, systematic effects, and the precision of two external inputs, the ratio f_{s}/f_{d} and the branching fraction of B^{0}→D[over ¯]^{0}K_{S}^{0}, which is used as a calibration channel.
Collapse
|
452
|
Niu J, Han X, Qi H, Yin J, Zhang Z, Zhang Z. Correlation between vascular endothelial growth factor and long-term prognosis in patients with acute myocardial infarction. Exp Ther Med 2016; 12:475-479. [PMID: 27347081 DOI: 10.3892/etm.2016.3286] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2014] [Accepted: 11/05/2015] [Indexed: 01/10/2023] Open
Abstract
The aim of the present study was to investigate the correlation between plasma the levels of vascular endothelial growth factor (VEGF) and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI). A total of 124 patients with AMI undergoing emergency percutaneous coronary intervention (PCI) were selected, and plasma VEGF levels were measured 7 days after the onset of AMI using an enzyme-linked immunosorbent assay. The patients were divided into the L (≤190 pg/ml VEGF) and H (>190 pg/ml VEGF) groups, and were followed up every 2 months for an average of 12 months. MACE were recorded during follow-up. On the basis of these results, the patients were further divided into the MACE and non-MACE (N-MACE) groups, and the serum VEGF concentration was compared between the two groups. At the 6-month follow-up, the incidence of MACE in the H group was found to be significantly reduced compared with the L group. The serum VEGF concentration in the N-MACE group was significantly higher compared with the MACE group. Multinomial logistic regression revealed that reduced VEGF levels (β=1.243; 95% CI, 1.018-1.326; P=0.026) were independent risk factors for MACE. In conclusion, high plasma VEGF levels at 7 days after AMI onset facilitate the long-term prognosis in the same infarct zone in patients with AMI, while low plasma VEGF levels are independent risk factors for MACE.
Collapse
|
453
|
Yang X, Su N, Shi Z, Xiang Z, He Y, Han X, Bai D. Effects of self-ligating brackets on oral hygiene and discomfort: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Dent Hyg 2016; 15:16-22. [PMID: 27095145 DOI: 10.1111/idh.12220] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2016] [Indexed: 02/05/2023]
|
454
|
Lu HH, Zhao Y, Chen TS, Xu KX, Wang W, Liu Q, Wen C, Li SS, Li XJ, Han X, Lin P. [Necessity of repeated roll test in horizontal semicircular canalithasis positioned diagnosis]. ZHONGHUA ER BI YAN HOU TOU JING WAI KE ZA ZHI = CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY 2016; 51:256-61. [PMID: 27095716 DOI: 10.3760/cma.j.issn.1673-0860.2016.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE To investigate the influence of repeated roll test in horizontal semicircular canalithasis(HSC-Can) positioned diagnosis, so as to investigate the cecessity of repeated roll test. METHODS The patients with a chief complaint of positional vertigo accepted two consecutive cycles roll test, the evoked nystagmus characteristics of each cycle recorded by video-nystagmuograph(VNG), whose direction, intensity, time and other parameters characteristics were analyzed in 51 HSC-Can. RESULTS Horizontal nystagmus in the same direction with turning were induced in HSC-Can roll test. In 51 HSC-Can, roll test cycle 1 and cycle 2 induced nystagmus same strength side in 26 cases(51.0%), of which 19 cases with stronger nystagmus intensity in cycle 2, another 7 cases were weaker; the opposite strength side of the two loops induced nystagmus, and cycle 1 evoked nystagmus intensity were weaker than cycle 2, based on cycle 2 results determined HSC-Can affected side in 25 cases (49.0%). Lesion and normal side in cycle 1 induced nystagmus duration (x±s, the same below) were (13.4±11.5)s and (14.1±9.9)s, respectively intensity (18.1±22.4)°/s and (13.0±12.0)°/s; as in cycle 2 induced nystagmus duration was (20.7±10.2)s and (18.0±12.0)s, strength respectively(40.4±28.0)°/s and (15.6 ±11.2)°/s. Cycle 2 ipsilateral rotor position evoked nystagmus showed longer duration and stronger intensity than cycle 1. Between two cycle induced ipsilateral nystagmus duration, intensity differences were statistically significant (t values were -4.233 and -5.154, P=0.000). 51 HSC-Can patients, 44 patients selected repositioning maneuver, after 1-2 times of maneuver, 41 cases (93.2%) showed complete resolution of symptoms, all cases's symptoms were improved; other 7 patients selected medication only. CONCLUSION The proposed suspicious HSC-Can patients should receive at least two cycles roll test, and mainly in the second cycle could determine the location of the responsible semicircular canals.
Collapse
|
455
|
Chan APC, Guo YP, Wong FKW, Li Y, Sun S, Han X. The development of anti-heat stress clothing for construction workers in hot and humid weather. ERGONOMICS 2016; 59:479-495. [PMID: 26399956 DOI: 10.1080/00140139.2015.1098733] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The purpose of this study was to develop anti-heat stress clothing for construction workers in hot and humid weather. Following DeJonge's functional clothing design process, the design situation was explored, including clothing fabric heat/moisture transporting properties and UV protection and the aspects of clothing ergonomic design (mobility, convenience, and safety). The problem structure was derived from the results of the surveys in three local construction sites, which agreed well with the task requirements and observations. Specifications were consequently described and 30 commercially available fabrics were identified and tested. Fabric testing data and design considerations were inputted in S-smart system to predict the thermal functional performance of the clothing. A new uniform prototype was developed and evaluated. The results of all measurements suggest that the new uniform which incorporated fabrics with superior heat/moisture transporting properties and loose-fitting design could reduce the workers' heat stress and improve their comfort and work performance. Practitioner Summary: The construction workers' uniform currently used in Hong Kong during summer was unsatisfactory. Following DeJonge's functional clothing design process, an anti-heat stress uniform was developed by testing 30 fabrics and predicting clothing thermal functional performance using S-smart system. The new uniform could reduce the workers' heat stress and improve their comfort and work performance.
Collapse
|
456
|
Yang LJ, Gao W, Bai JY, Zhang XK, Han X, Sun YH, Zhang LL, Zhang MM. Correlation between Interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2016; 20:1271-1282. [PMID: 27097946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE The present study aims to investigate the correlation between Interleukin (IL)-17 gene polymorphism with gastric cancer susceptibility in Han Chinese population. PATIENTS AND METHODS Between November 2013 and October 2014, 386 patients with gastric cancer who had undergone surgeries at our institution and 374 age- and sex-matched healthy controls were included in this study. Single nucleotide polymorphisms (SNPs) of IL-17 gene (rs2275913, rs3748067, rs4711998 and rs763780) in patients and health controls were studied by using restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) and DNA sequencing technology. The correlation between IL-17 polymorphism and gastric cancer susceptibility was analyzed using logistic regression analysis. RESULTS For IL17 rs2275913, no significant differences were observed in the frequencies of AA genotype and A allele between patients and controls (c2 = 0.870 p > 0.05; c2 = 0.814 p > 0.05). In IL17 rs3748067, the frequencies of TT genotype and T allele were significantly higher in patients than in controls (c2 = 12.82 p < 0.01; c2 = 12.805 p < 0.01). For IL17A rs4711998, no significant differences were observed in the frequencies of AA genotype and A allele between patients and controls (c2 = 2.636, p > 0.05; c2 = 1.462, p > 0.05). As for ILl7F rs763780, the frequencies of GG genotype and G allele in patients were significantly different from those in controls (c2 = 16.534, p < 0.01; c2 = 16.399, p < 0.01). CONCLUSIONS Polymorphism of IL-17 rs3748067 and rs763780 is closely associated with gastric cancer development. Polymorphism of L-17 rs2275913 and rs4711998 may be correlated with the risk for gastric cancer.
Collapse
|
457
|
Park JY, Han X, Piao MJ, Oh MC, Fernando PMDJ, Kang KA, Ryu YS, Jung U, Kim IG, Hyun JW. Hyperoside Induces Endogenous Antioxidant System to Alleviate Oxidative Stress. J Cancer Prev 2016; 21:41-7. [PMID: 27051648 PMCID: PMC4819665 DOI: 10.15430/jcp.2016.21.1.41] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2016] [Revised: 02/26/2016] [Accepted: 02/26/2016] [Indexed: 11/18/2022] Open
Abstract
Background: Hyperoside, a flavonoid which is mainly found in Hypericum perforatum L., has many biological effects. One of the most important effects is to prevent the oxidative stress induced by reactive oxygen species. However, the molecular mechanisms underlying its effect are not fully understood. Oxidative stress is implicated in the occurrence of various physical diseases. A wide array of enzymatic antioxidant defense systems include NADH: quinone oxidoreductase 1, superoxide dismutase, and heme oxygenase-1 (HO-1). In the present study, the protective effects of hyperoside against hydrogen peroxide-induced oxidative stress in human lens epithelial cells, HLE-B3, were investigated in terms of HO-1 induction. Methods: The protein and mRNA expressions of HO-1 were examined by Western blotting and reverse transcriptase-PCR assays, respectively. To evaluate the ability of hyperoside to activate nuclear factor erythroid 2-related factor 2 (Nrf2), Western blotting and electrophoretic mobility shift assay were performed with nuclear extracts prepared from HLE-B3 cells treated with hyperoside. The activation of extracellular signal-regulated kinase (ERK), the upstream kinase of Nrf2 signaling, was monitored by Western blot analysis. The protective effect of hyperoside in HLE-B3 cells against hydrogen peroxide was performed by MTT assay. Results: Hyperoside increased both the mRNA and protein expression of HO-1 in a time- and dose-dependent manner. In addition, hyperoside elevated the level of of Nrf2 and its antioxidant response element-binding activity, which was modulated by upstream of ERK. Moreover, it activated ERK and restored cell viability which was decreased by hydrogen peroxide. Conclusions: Hyperoside is an effective compound to protect cells against oxidative stress via HO-1 induction.
Collapse
|
458
|
Ren Q, Han X, Zhang S, Cai X, Ji L. Combined Influence of Genetic Variants and Gene-gene Interaction on Sulfonylurea Efficacy in Type 2 Diabetic Patients. Exp Clin Endocrinol Diabetes 2016; 124:157-62. [PMID: 27008632 DOI: 10.1055/s-0035-1564161] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
459
|
Han X, Liang WL, Zhang Y, Sun LD, Liang WY. Effect of atmospheric fine particles on epidermal growth factor receptor mRNA expression in mouse skin tissue. GENETICS AND MOLECULAR RESEARCH 2016; 15:gmr7188. [PMID: 27050971 DOI: 10.4238/gmr.15017188] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
We investigated the effect of atmospheric fine particles on epidermal growth factor receptor (Egfr) mRNA expression in mouse skin tissue and explored the effect of atmospheric fine particles on skin aging. Forty female BALB/c mice were randomly divided into four groups (each comprising 10 mice) as follows: a saline control group and low-, medium-, and high-dose atmospheric fine particle groups (1.6, 8.0, and 40.0 mg/kg, respectively) (fine particles were defined as those with a diameter of £2.5 mm, i.e., PM2.5). Each dose group was exposed to intratracheal instillation for 3 days. Twenty-four hours after the last exposure, real-time quantitative polymerase chain reaction was used to detect the expression of Egfr mRNA in the skin tissue of each mouse. The expression levels of Egfr mRNA in the medium- and high-dose PM2.5 groups were significantly higher (P < 0.05) than that in the control group, and were positively correlated with the dose. Medium and high concentrations of PM2.5 can induce the expression of Egfr mRNA and promote skin aging.
Collapse
|
460
|
Duan MH, Han X, Li J, Zhang W, Zhu TN, Han B, Zhuang JL, Wang SJ, Cao XX, Cai HC, Chen M, Yang C, Zhou DB. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study. Leuk Res 2016; 42:43-6. [PMID: 26859782 DOI: 10.1016/j.leukres.2016.01.012] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2015] [Revised: 12/29/2015] [Accepted: 01/24/2016] [Indexed: 01/25/2023]
Abstract
OBJECTIVE We compared the efficacy and clinical outcomes of vindesine and prednisone (VP) and cyclophosphamide, etoposide, vindesine, and prednisone (CEVP) regimens as first-line treatment for multisystem (MS) or multifocal single system (SS-m) adult Langerhans cell histiocytosis (LCH). METHOD Clinical features, treatment response, and survival of adults with Langerhans cell histiocytosis treated at our center from January 2001 to January 2015 were reviewed retrospectively. RESULTS Forty-five adult MS or SS-m LCH patients were treated (N=31, CEVP group; N=14, VP group). Both treatment groups had similar gender distributions, patient ages, and extent of disease. The non-active disease rate for both groups was 70.0% and 64.3% (P=0.775), respectively. Median follow-up was 74.9 (range: 2.8-183.6) months and recurrence rates were 71.0% and 78.6% (P=0.593), respectively. The need for second-line therapy was 64.5% and 71.4% (P=0.649), respectively, and mortality rates were 9.7% and 15.4% (P=0.586), respectively. Neutropenia occurred in 48.4% of CEVP-treated patients and 7.1% of VP-treated patients (P=0.008). CONCLUSIONS CEVP or VP regimens for the treatment of adult SS-m or MS LCH showed similar efficacies, and both regimens were associated with high disease recurrence and the need for second-line therapy.
Collapse
|
461
|
Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics. Clin Pharmacol Ther 2016; 99:538-47. [PMID: 26566262 DOI: 10.1002/cpt.297] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Accepted: 11/07/2015] [Indexed: 12/15/2022]
Abstract
Drug-drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assessed whether sulfonylurea use with a statin or fibrate was associated with severe hypoglycemia. We conducted cohort studies of users of glyburide, glipizide, and glimepiride plus a statin or fibrate within a Medicaid population. The outcome was a validated, diagnosis-based algorithm for severe hypoglycemia. Among 592,872 persons newly exposed to a sulfonylurea+antihyperlipidemic, the incidence of severe hypoglycemia was 5.8/100 person-years. Adjusted hazard ratios (HRs) for sulfonylurea+statins were consistent with no association. Most overall HRs for sulfonylurea+fibrate were elevated, with sulfonylurea-specific adjusted HRs as large as 1.50 (95% confidence interval (CI): 1.24-1.81) for glyburide+gemfibrozil, 1.37 (95% CI: 1.11-1.69) for glipizide+gemfibrozil, and 1.63 (95% CI: 1.29-2.06) for glimepiride+fenofibrate. Concomitant therapy with a sulfonylurea and fibrate is associated with an often delayed increased rate of severe hypoglycemia.
Collapse
|
462
|
Yang X, Zhang K, Ye X, Zheng A, Huang G, Li W, Wei Z, Wang J, Han X, Ni X, Meng M, Ni Y, Yuan Q, Xing C. Artificial pneumothorax for pain relief during microwave ablation of subpleural lung tumors. Indian J Cancer 2016; 52 Suppl 2:e80-3. [PMID: 26728680 DOI: 10.4103/0019-509x.172519] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND When microwave ablation (MWA) is used for subpleural lesions, severe pain was the common side effect under the local anesthesia conditions during the procedure and postprocedure. To study the pain relief effect of artificial pneumothorax in the treatment of subpleural lung tumors with MWA. MATERIALS AND METHODS From February 2012 to October 2014, 37 patients with 40 subpleural lung tumors underwent MWA, including 17 patients of 19 sessions given artificial pneumothorax prior to MWA (group-I), and 20 patients of 21 sessions without artificial pneumothorax (group-II). Patient's pain assessment scores (10-point visual analog scale [VAS]) at during-procedure, 6, 12, 24, and 48 h after the MWA procedure and mean 24 h morphine dose were compared between the two groups. Complications of the artificial pneumothorax were also summarized. RESULTS Pain VAS were 0.53, 0.65, 1.00, 0.24, and 0.18 at during-procedure, 6, 12, 24, and 48 h for group-I and 5.53, 2.32, 2.82, 1.21, and 0.21 for group-II, respectively. Pain VAS in group I was significantly decreased at during-procedure, 6, 12, and 24 h after the MWA (P < 0.001). No statistical pain VAS difference was observed at 48 h after the MWA between the two groups (P > 0.05). The mean 24 h morphine dose was 5.00 mg in group-I and 12.63 mg in group-II (P = 0.000). "Artificial pneumothorax" related complications occurred in two patients from group-I, including one pleural effusion and one minor hemoptysis. No patient in group-I and group-II died during the procedure or in 30 days after MWA. CONCLUSION Artificial pneumothorax is a safe and effective method for pain relief during MWA of subpleural lung tumors.
Collapse
|
463
|
Han P, Zhao J, Guo Q, Wang J, Zhang W, Shen S, Wang X, Dong R, Ma Y, Kang L, Fu L, Jia L, Han X, He Z, Bao Y, Wang L, Niu K. Incidence, Risk Factors, and the Protective Effect of High Body Mass Index against Sarcopenia in Suburb-Dwelling Elderly Chinese Populations. J Nutr Health Aging 2016; 20:1056-1060. [PMID: 27925147 DOI: 10.1007/s12603-016-0704-3] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND Few studies have explored the risk factors of sarcopenia in certain cohorts. The objective of this study was to examine the incidence of sarcopenia and associated factors over a 1-year period in an elderly Chinese suburban population. METHODS This study was conducted on 356 Chinese suburb-dwelling participants aged ≥60 years, for whom detailed information regarding sociodemographics, behavioral characteristics, and medical conditions had been documented. Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS) criteria. Sarcopenia incidence was documented after one year of follow-up, and correlated with several possible factors. RESULTS At baseline, 64 (9.7%) of the initial 657 participants had sarcopenia. The prevalence of sarcopenia was 10.4% after one year. Between baseline and 1-year follow-up, 13 of the participants without sarcopenia at baseline had developed sarcopenia. After multivariate adjustments, it was found that the incidence of sarcopenia increased with age and high body mass index (BMI) is associated with less incidence of sarcopenia. Incidence was also higher among women. CONCLUSIONS We found sarcopenia incidence increased with age, and women were more likely to have sarcopenia. A higher BMI is also associated with a lower incidence of sarcopenia. Maintaining a healthy weight could be beneficial in the prevention of sarcopenia.
Collapse
|
464
|
An L, Han X, Li H, Ma Y, Shi L, Xu G, Yuan G, Sun J, Zhao N, Sheng Y, Wang M, Du P. Effects and mechanism of cerebroprotein hydrolysate on learning and memory ability in mice. GENETICS AND MOLECULAR RESEARCH 2016; 15:gmr8804. [DOI: 10.4238/gmr.15038804] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
465
|
Han X, Critser JK. A Theoretical and Experimental Investigation of Mechanical Damage to Rodent Sperm Generated by Microscale Ice Formation. CRYO LETTERS 2016; 37:388-393. [PMID: 28072424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
UNLABELLED BACKGROUND: Rodent sperm cryopreservation is of critical importance for the maintenance of lines or strains of genetically engineered mice and rats. However, rodent sperm are extremely mechanically sensitive due to their unusual morphology, and are severely damaged using current methods of cryopreservation. Those methods result in poor post thaw motility (PTM) for mouse. OBJECTIVE To investigate the mechanism of mechanical damage introduced to rodent sperm during freezing, a micro-mechanical model was established to analyze the sperm radial and axial thermal stresses generated by microscale extracellular ice formation. MATERIALS AND METHODS PTM of mouse sperm cryopreserved in capillaries of different radii (100, 200, 344, 526, 775µm) was measured using a standard computer-assisted sperm analysis system. RESULTS The model predicts that when one of the inner dimensions of the containers (the inner diameter of plastic straws or straw capillaries) is on the same order of magnitude of sperm length, axial stress is significantly increased. The experimental results showed that the value of PTM was decreased from 38 ± 8 % in the larger (775µm) capillaries to 0 ± 0 % in the smaller (100 µm) ones. CONCLUSION Theoretical analysis based on the established model were experimentally validated and can be used to guide the design of novel devices to improve the efficiency of rodent sperm cryopreservation.
Collapse
|
466
|
Zheng J, Hewage SRKM, Piao MJ, Kang KA, Han X, Kang HK, Yoo ES, Koh YS, Lee NH, Ko CS, Lee JC, Ko MH, Hyuna JW. Photoprotective Effect of Carpomitra costata Extract against Ultraviolet B-Induced Oxidative Damage in Human Keratinocytes. J Environ Pathol Toxicol Oncol 2016; 35:11-28. [PMID: 27279581 DOI: 10.1615/jenvironpatholtoxicoloncol.2016014003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Natural marine products show various biological properties such as antiphotoaging, antioxidant, anticancer, and anti-inflammation. This study evaluated the protective effects of the brown alga Carpomitra costata (Stackhouse) Batters (Sporochnaceae) against ultraviolet B (UVB)-provoked damage in human HaCaT keratinocytes. C. costata extract (CCE) effectively reduced superoxide anion, hydroxyl radical, and UVB-stimulated intracellular reactive oxygen species (ROS) levels. CCE also restored the expression and activity of UVB-suppressed antioxidant enzymes. Furthermore, CCE decreased UVB-triggered oxidative damage to cellular components including DNA, protein, and lipid and defended the cells against mitochondrial membrane depolarization-medicated apoptosis. The results of this study indicate that CCE can safeguard human keratinocytes against UVB-induced cellular damage via a potent antioxidant mechanism. CCE may find utility as part of a therapeutic arsenal against the damaging effects of UVB radiation on the skin.
Collapse
|
467
|
Han X. Direct Microscale Measurement of Mouse Oocyte Membrane Permeability to Water and Ethylene Glycol at Subzero Temperatures Using Cryomicroscopy. CRYO LETTERS 2016; 37:394-400. [PMID: 28072425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
UNLABELLED BACKGROUND: Investigation of cell osmotic behavior at subzero temperatures is of critical importance to the optimization of cooling procedures for cryopreservation. Based on established thermodynamic models, plasma membrane permeability coefficients for water and cryoprotectant agent (CPA) (Lcpa, Pp) and their activation energies (EaLp, EaPcpa) are essential to predict the change of cell volume and composition of intracellular solutions corresponding to different cooling procedures. However, currently available methods to measure Lp at subzero temperatures suffer from technical difficulties due to ice formation and there are no generalized methods to measure Pcpa at subzero temperatures. OBJECTIVE The present study aims to investigate cell osmotic behavior at subzero temperatures without ice formation. MATERIALS AND METHODS In the study cells were directly injected into super-cooled CPA solutions mounted on a cryomicroscope, and the corresponding osmotic properties were measured. RESULTS Using ethylene glycol (EG), the value of PEG for mouse (CD-1) metaphase II oocytes at 0, -5, -10 degree C was determined to be 8.451.20, 7.430.91, 6.401.10, x10-6 cm/min, respectively, and EaPEG was calculated to be 3.9 kCal/mol. Lp in the presence of EG (LpEG) at 0, -5, -10 , -15 degree C was determined to be 7.0 1.15, 4.90 1.20, 2.44 0.31, 1.200.24, x 10-2 µm/min/atm, respectively, and EaLp was calculated to be 15.5 kCal/mol. CONCLUSION Comparing these values with those previously measured at superzero temperatures, we concluded that for mouse oocytes, the Arrhenius relationship for LpEG is consistent at superzero and subzero temperatures, but the values of PEG at subzero temperatures are much lower than the extrapolated values from the Arrhenius relationship at superzero temperatures, possibly caused by membrane phase transition at low temperatures.
Collapse
|
468
|
Zhang Q, Chen H, Han X, Cai J, Yang Y, Liu M, Zhang K. Graphene-Encapsulated Nanosheet-Assembled Zinc–Nickel–Cobalt Oxide Microspheres for Enhanced Lithium Storage. CHEMSUSCHEM 2016; 9:128. [PMID: 26777303 DOI: 10.1002/cssc.201600017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|
469
|
Aaij R, Adeva B, Adinolfi M, Affolder A, Ajaltouni Z, Akar S, Albrecht J, Alessio F, Alexander M, Ali S, Alkhazov G, Alvarez Cartelle P, Alves Jr AA, Amato S, Amerio S, Amhis Y, An L, Anderlini L, Anderson J, Andreotti M, Andrews JE, Appleby RB, Aquines Gutierrez O, Archilli F, d’Argent P, Artamonov A, Artuso M, Aslanides E, Auriemma G, Baalouch M, Bachmann S, Back JJ, Badalov A, Baesso C, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Batozskaya V, Battista V, Bay A, Beaucourt L, Beddow J, Bedeschi F, Bediaga I, Bel LJ, Belyaev I, Ben-Haim E, Bencivenni G, Benson S, Benton J, Berezhnoy A, Bernet R, Bertolin A, Bettler MO, van Beuzekom M, Bien A, Bifani S, Bird T, Birnkraut A, Bizzeti A, Blake T, Blanc F, Blouw J, Blusk S, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borgia A, Borsato M, Bowcock TJV, Bowen E, Bozzi C, Brett D, Britsch M, Britton T, Brodzicka J, Brook NH, Bursche A, Buytaert J, Cadeddu S, Calabrese R, Calvi M, Calvo Gomez M, Campana P, Campora Perez D, Capriotti L, Carbone A, Carboni G, Cardinale R, Cardini A, Carniti P, Carson L, Carvalho Akiba K, Casanova Mohr R, Casse G, Cassina L, Castillo Garcia L, Cattaneo M, Cauet C, Cavallero G, Cenci R, Charles M, Charpentier P, Chefdeville M, Chen S, Cheung SF, Chiapolini N, Chrzaszcz M, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coco V, Cogan J, Cogneras E, Cogoni V, Cojocariu L, Collazuol G, Collins P, Comerma-Montells A, Contu A, Cook A, Coombes M, Coquereau S, Corti G, Corvo M, Counts I, Couturier B, Cowan GA, Craik DC, Crocombe A, Cruz Torres M, Cunliffe S, Currie R, D’Ambrosio C, Dalseno J, David PNY, Davis A, De Bruyn K, De Capua S, De Cian M, De Miranda JM, De Paula L, De Silva W, De Simone P, Dean CT, Decamp D, Deckenhoff M, Del Buono L, Déléage N, Derkach D, Deschamps O, Dettori F, Dey B, Di Canto A, Di Ruscio F, Dijkstra H, Donleavy S, Dordei F, Dorigo M, Dosil Suárez A, Dossett D, Dovbnya A, Dreimanis K, Dujany G, Dupertuis F, Durante P, Dzhelyadin R, Dziurda A, Dzyuba A, Easo S, Egede U, Egorychev V, Eidelman S, Eisenhardt S, Eitschberger U, Ekelhof R, Eklund L, El Rifai I, Elsasser C, Ely S, Esen S, Evans HM, Evans T, Falabella A, Färber C, Farinelli C, Farley N, Farry S, Fay R, Ferguson D, Fernandez Albor V, Ferrari F, Ferreira Rodrigues F, Ferro-Luzzi M, Filippov S, Fiore M, Fiorini M, Firlej M, Fitzpatrick C, Fiutowski T, Fol P, Fontana M, Fontanelli F, Forty R, Francisco O, Frank M, Frei C, Frosini M, Fu J, Furfaro E, Gallas Torreira A, Galli D, Gallorini S, Gambetta S, Gandelman M, Gandini P, Gao Y, García Pardiñas J, Garofoli J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauld R, Gavardi L, Gazzoni G, Geraci A, Gerick D, Gersabeck E, Gersabeck M, Gershon T, Ghez P, Gianelle A, Gianì S, Gibson V, Giubega L, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gotti C, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graverini E, Graziani G, Grecu A, Greening E, Gregson S, Griffith P, Grillo L, Grünberg O, Gui B, Gushchin E, Guz Y, Gys T, Hadjivasiliou C, Haefeli G, Haen C, Haines SC, Hall S, Hamilton B, Hampson T, Han X, Hansmann-Menzemer S, Harnew N, Harnew ST, Harrison J, He J, Head T, Heijne V, Hennessy K, Henrard P, Henry L, Hernando Morata JA, van Herwijnen E, Heß M, Hicheur A, Hill D, Hoballah M, Hombach C, Hulsbergen W, Humair T, Hussain N, Hutchcroft D, Hynds D, Idzik M, Ilten P, Jacobsson R, Jaeger A, Jalocha J, Jans E, Jawahery A, Jing F, John M, Johnson D, Jones CR, Joram C, Jost B, Jurik N, Kandybei S, Kanso W, Karacson M, Karbach TM, Karodia S, Kelsey M, Kenyon IR, Kenzie M, Ketel T, Khanji B, Khurewathanakul C, Klaver S, Klimaszewski K, Kochebina O, Kolpin M, Komarov I, Koopman RF, Koppenburg P, Kravchuk L, Kreplin K, Kreps M, Krocker G, Krokovny P, Kruse F, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kurek K, Kvaratskheliya T, La Thi VN, Lacarrere D, Lafferty G, Lai A, Lambert D, Lambert RW, Lanfranchi G, Langenbruch C, Langhans B, Latham T, Lazzeroni C, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Leroy O, Lesiak T, Leverington B, Li Y, Likhomanenko T, Liles M, Lindner R, Linn C, Lionetto F, Liu B, Lohn S, Longstaff I, Lopes JH, Lucchesi D, Luo H, Lupato A, Luppi E, Lupton O, Machefert F, Machikhiliyan IV, Maciuc F, Maev O, Malde S, Malinin A, Manca G, Mancinelli G, Manning P, Mapelli A, Maratas J, Marchand JF, Marconi U, Marin Benito C, Marino P, Märki R, Marks J, Martellotti G, Martinelli M, Martinez Santos D, Martinez Vidal F, Martins Tostes D, Massafferri A, Matev R, Mathe Z, Matteuzzi C, Mauri A, Maurin B, Mazurov A, McCann M, McCarthy J, McNab A, McNulty R, McSkelly B, Meadows B, Meier F, Meissner M, Merk M, Milanes DA, Minard MN, Mitzel DS, Molina Rodriguez J, Monteil S, Morandin M, Morawski P, Mordà A, Morello MJ, Moron J, Morris AB, Mountain R, Muheim F, Müller J, Müller K, Müller V, Mussini M, Muster B, Naik P, Nakada T, Nandakumar R, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neuner M, Nguyen AD, Nguyen TD, Nguyen-Mau C, Niess V, Niet R, Nikitin N, Nikodem T, Novoselov A, O’Hanlon DP, Oblakowska-Mucha A, Obraztsov V, Ogilvy S, Okhrimenko O, Oldeman R, Onderwater CJG, Osorio Rodrigues B, Otalora Goicochea JM, Otto A, Owen P, Oyanguren A, Palano A, Palombo F, Palutan M, Panman J, Papanestis A, Pappagallo M, Pappalardo LL, Parkes C, Passaleva G, Patel GD, Patel M, Patrignani C, Pearce A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perret P, Pescatore L, Petridis K, Petrolini A, Picatoste Olloqui E, Pietrzyk B, Pilař T, Pinci D, Pistone A, Playfer S, Plo Casasus M, Poikela T, Polci F, Poluektov A, Polyakov I, Polycarpo E, Popov A, Popov D, Popovici B, Potterat C, Price E, Price JD, Prisciandaro J, Pritchard A, Prouve C, Pugatch V, Puig Navarro A, Punzi G, Qian W, Quagliani R, Rachwal B, Rademacker JH, Rakotomiaramanana B, Rama M, Rangel MS, Raniuk I, Rauschmayr N, Raven G, Redi F, Reichert S, Reid MM, dos Reis AC, Ricciardi S, Richards S, Rihl M, Rinnert K, Rives Molina V, Robbe P, Rodrigues AB, Rodrigues E, Rodriguez Perez P, Roiser S, Romanovsky V, Romero Vidal A, Rotondo M, Rouvinet J, Ruf T, Ruiz H, Ruiz Valls P, Saborido Silva JJ, Sagidova N, Sail P, Saitta B, Salustino Guimaraes V, Sanchez Mayordomo C, Sanmartin Sedes B, Santacesaria R, Santamarina Rios C, Santovetti E, Sarti A, Satriano C, Satta A, Saunders DM, Savrina D, Schiller M, Schindler H, Schlupp M, Schmelling M, Schmelzer T, Schmidt B, Schneider O, Schopper A, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Semennikov A, Sepp I, Serra N, Serrano J, Sestini L, Seyfert P, Shapkin M, Shapoval I, Shcheglov Y, Shears T, Shekhtman L, Shevchenko V, Shires A, Silva Coutinho R, Simi G, Sirendi M, Skidmore N, Skillicorn I, Skwarnicki T, Smith E, Smith E, Smith J, Smith M, Snoek H, Sokoloff MD, Soler FJP, Soomro F, Souza D, Souza De Paula B, Spaan B, Spradlin P, Sridharan S, Stagni F, Stahl M, Stahl S, Steinkamp O, Stenyakin O, Sterpka F, Stevenson S, Stoica S, Stone S, Storaci B, Stracka S, Straticiuc M, Straumann U, Stroili R, Sun L, Sutcliffe W, Swientek K, Swientek S, Syropoulos V, Szczekowski M, Szczypka P, Szumlak T, T’Jampens S, Tekampe T, Teklishyn M, Tellarini G, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Todd J, Tolk S, Tomassetti L, Tonelli D, Topp-Joergensen S, Torr N, Tournefier E, Tourneur S, Trabelsi K, Tran MT, Tresch M, Trisovic A, Tsaregorodtsev A, Tsopelas P, Tuning N, Ubeda Garcia M, Ukleja A, Ustyuzhanin A, Uwer U, Vacca C, Vagnoni V, Valenti G, Vallier A, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Veneziano G, Vesterinen M, Viaud B, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vollhardt A, Volyanskyy D, Voong D, Vorobyev A, Vorobyev V, Voß C, de Vries JA, Waldi R, Wallace C, Wallace R, Walsh J, Wandernoth S, Wang J, Ward DR, Watson NK, Websdale D, Weiden A, Whitehead M, Wiedner D, Wilkinson G, Wilkinson M, Williams M, Williams MP, Williams M, Wilson FF, Wimberley J, Wishahi J, Wislicki W, Witek M, Wormser G, Wotton SA, Wright S, Wyllie K, Xie Y, Xu Z, Yang Z, Yuan X, Yushchenko O, Zangoli M, Zavertyaev M, Zhang L, Zhang Y, Zhelezov A, Zhokhov A, Zhong L. Search for long-lived heavy charged particles using a ring imaging Cherenkov technique at LHCb. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2015; 75:595. [PMID: 26709346 PMCID: PMC4684630 DOI: 10.1140/epjc/s10052-015-3809-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/01/2015] [Accepted: 11/24/2015] [Indexed: 06/05/2023]
Abstract
A search is performed for heavy long-lived charged particles using 3.0 [Formula: see text] of proton-proton collisions collected at [Formula: see text][Formula: see text] 7 and 8 TeV with the LHCb detector. The search is mainly based on the response of the ring imaging Cherenkov detectors to distinguish the heavy, slow-moving particles from muons. No evidence is found for the production of such long-lived states. The results are expressed as limits on the Drell-Yan production of pairs of long-lived particles, with both particles in the LHCb pseudorapidity acceptance, [Formula: see text]. The mass-dependent cross-section upper limits are in the range 2-4 fb (at 95 % CL) for masses between 14 and 309 [Formula: see text].
Collapse
|
470
|
Aaij R, Abellán Beteta C, Adeva B, Adinolfi M, Affolder A, Ajaltouni Z, Akar S, Albrecht J, Alessio F, Alexander M, Ali S, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amerio S, Amhis Y, An L, Anderlini L, Anderson J, Andreassi G, Andreotti M, Andrews JE, Appleby RB, Aquines Gutierrez O, Archilli F, d'Argent P, Artamonov A, Artuso M, Aslanides E, Auriemma G, Baalouch M, Bachmann S, Back JJ, Badalov A, Baesso C, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Batozskaya V, Battista V, Bay A, Beaucourt L, Beddow J, Bedeschi F, Bediaga I, Bel LJ, Bellee V, Belloli N, Belyaev I, Ben-Haim E, Bencivenni G, Benson S, Benton J, Berezhnoy A, Bernet R, Bertolin A, Bettler MO, van Beuzekom M, Bien A, Bifani S, Billoir P, Bird T, Birnkraut A, Bizzeti A, Blake T, Blanc F, Blouw J, Blusk S, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borisyak M, Borsato M, Bowcock TJV, Bowen E, Bozzi C, Braun S, Britsch M, Britton T, Brodzicka J, Brook NH, Buchanan E, Burr C, Bursche A, Buytaert J, Cadeddu S, Calabrese R, Calvi M, Calvo Gomez M, Campana P, Campora Perez D, Capriotti L, Carbone A, Carboni G, Cardinale R, Cardini A, Carniti P, Carson L, Carvalho Akiba K, Casse G, Cassina L, Castillo Garcia L, Cattaneo M, Cauet C, Cavallero G, Cenci R, Charles M, Charpentier P, Chefdeville M, Chen S, Cheung SF, Chiapolini N, Chrzaszcz M, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coco V, Cogan J, Cogneras E, Cogoni V, Cojocariu L, Collazuol G, Collins P, Comerma-Montells A, Contu A, Cook A, Coombes M, Coquereau S, Corti G, Corvo M, Couturier B, Cowan GA, Craik DC, Crocombe A, Cruz Torres M, Cunliffe S, Currie R, D'Ambrosio C, Dall'Occo E, Dalseno J, David PNY, Davis A, De Aguiar Francisco O, De Bruyn K, De Capua S, De Cian M, De Miranda JM, De Paula L, De Simone P, Dean CT, Decamp D, Deckenhoff M, Del Buono L, Déléage N, Demmer M, Derkach D, Deschamps O, Dettori F, Dey B, Di Canto A, Di Ruscio F, Dijkstra H, Donleavy S, Dordei F, Dorigo M, Dosil Suárez A, Dossett D, Dovbnya A, Dreimanis K, Dufour L, Dujany G, Durante P, Dzhelyadin R, Dziurda A, Dzyuba A, Easo S, Egede U, Egorychev V, Eidelman S, Eisenhardt S, Eitschberger U, Ekelhof R, Eklund L, El Rifai I, Elsasser C, Ely S, Esen S, Evans HM, Evans T, Falabella A, Färber C, Farley N, Farry S, Fay R, Ferguson D, Fernandez Albor V, Ferrari F, Ferreira Rodrigues F, Ferro-Luzzi M, Filippov S, Fiore M, Fiorini M, Firlej M, Fitzpatrick C, Fiutowski T, Fohl K, Fol P, Fontana M, Fontanelli F, Forshaw DC, Forty R, Frank M, Frei C, Frosini M, Fu J, Furfaro E, Gallas Torreira A, Galli D, Gallorini S, Gambetta S, Gandelman M, Gandini P, Gao Y, García Pardiñas J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauld R, Gavardi L, Gazzoni G, Gerick D, Gersabeck E, Gersabeck M, Gershon T, Ghez P, Gianì S, Gibson V, Girard OG, Giubega L, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gotti C, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graverini E, Graziani G, Grecu A, Greening E, Gregson S, Griffith P, Grillo L, Grünberg O, Gui B, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haines SC, Hall S, Hamilton B, Han X, Hansmann-Menzemer S, Harnew N, Harnew ST, Harrison J, He J, Head T, Heijne V, Hennessy K, Henrard P, Henry L, van Herwijnen E, Heß M, Hicheur A, Hill D, Hoballah M, Hombach C, Hulsbergen W, Humair T, Hussain N, Hutchcroft D, Hynds D, Idzik M, Ilten P, Jacobsson R, Jaeger A, Jalocha J, Jans E, Jawahery A, John M, Johnson D, Jones CR, Joram C, Jost B, Jurik N, Kandybei S, Kanso W, Karacson M, Karbach TM, Karodia S, Kecke M, Kelsey M, Kenyon IR, Kenzie M, Ketel T, Khairullin E, Khanji B, Khurewathanakul C, Klaver S, Klimaszewski K, Kochebina O, Kolpin M, Komarov I, Koopman RF, Koppenburg P, Kozeiha M, Kravchuk L, Kreplin K, Kreps M, Krocker G, Krokovny P, Kruse F, Krzemien W, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kuonen AK, Kurek K, Kvaratskheliya T, Lacarrere D, Lafferty G, Lai A, Lambert D, Lanfranchi G, Langenbruch C, Langhans B, Latham T, Lazzeroni C, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Lemos Cid E, Leroy O, Lesiak T, Leverington B, Li Y, Likhomanenko T, Liles M, Lindner R, Linn C, Lionetto F, Liu B, Liu X, Loh D, Longstaff I, Lopes JH, Lucchesi D, Lucio Martinez M, Luo H, Lupato A, Luppi E, Lupton O, Lusiani A, Machefert F, Maciuc F, Maev O, Maguire K, Malde S, Malinin A, Manca G, Mancinelli G, Manning P, Mapelli A, Maratas J, Marchand JF, Marconi U, Marin Benito C, Marino P, Marks J, Martellotti G, Martin M, Martinelli M, Martinez Santos D, Martinez Vidal F, Martins Tostes D, Massafferri A, Matev R, Mathad A, Mathe Z, Matteuzzi C, Mauri A, Maurin B, Mazurov A, McCann M, McCarthy J, McNab A, McNulty R, Meadows B, Meier F, Meissner M, Melnychuk D, Merk M, Michielin E, Milanes DA, Minard MN, Mitzel DS, Molina Rodriguez J, Monroy IA, Monteil S, Morandin M, Morawski P, Mordà A, Morello MJ, Moron J, Morris AB, Mountain R, Muheim F, Müller D, Müller J, Müller K, Müller V, Mussini M, Muster B, Naik P, Nakada T, Nandakumar R, Nandi A, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neuner M, Nguyen AD, Nguyen TD, Nguyen-Mau C, Niess V, Niet R, Nikitin N, Nikodem T, Novoselov A, O'Hanlon DP, Oblakowska-Mucha A, Obraztsov V, Ogilvy S, Okhrimenko O, Oldeman R, Onderwater CJG, Osorio Rodrigues B, Otalora Goicochea JM, Otto A, Owen P, Oyanguren A, Palano A, Palombo F, Palutan M, Panman J, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parker W, Parkes C, Passaleva G, Patel GD, Patel M, Patrignani C, Pearce A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perret P, Pescatore L, Petridis K, Petrolini A, Petruzzo M, Picatoste Olloqui E, Pietrzyk B, Pilař T, Pinci D, Pistone A, Piucci A, Playfer S, Plo Casasus M, Poikela T, Polci F, Poluektov A, Polyakov I, Polycarpo E, Popov A, Popov D, Popovici B, Potterat C, Price E, Price JD, Prisciandaro J, Pritchard A, Prouve C, Pugatch V, Puig Navarro A, Punzi G, Qian W, Quagliani R, Rachwal B, Rademacker JH, Rama M, Ramos Pernas M, Rangel MS, Raniuk I, Rauschmayr N, Raven G, Redi F, Reichert S, Reid MM, Dos Reis AC, Ricciardi S, Richards S, Rihl M, Rinnert K, Rives Molina V, Robbe P, Rodrigues AB, Rodrigues E, Rodriguez Lopez JA, Rodriguez Perez P, Roiser S, Romanovsky V, Romero Vidal A, Ronayne JW, Rotondo M, Ruf T, Ruiz Valls P, Saborido Silva JJ, Sagidova N, Sail P, Saitta B, Salustino Guimaraes V, Sanchez Mayordomo C, Sanmartin Sedes B, Santacesaria R, Santamarina Rios C, Santimaria M, Santovetti E, Sarti A, Satriano C, Satta A, Saunders DM, Savrina D, Schiller M, Schindler H, Schlupp M, Schmelling M, Schmelzer T, Schmidt B, Schneider O, Schopper A, Schubiger M, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Semennikov A, Serra N, Serrano J, Sestini L, Seyfert P, Shapkin M, Shapoval I, Shcheglov Y, Shears T, Shekhtman L, Shevchenko V, Shires A, Siddi BG, Silva Coutinho R, Silva de Oliveira L, Simi G, Sirendi M, Skidmore N, Skwarnicki T, Smith E, Smith E, Smith IT, Smith J, Smith M, Snoek H, Sokoloff MD, Soler FJP, Soomro F, Souza D, Souza De Paula B, Spaan B, Spradlin P, Sridharan S, Stagni F, Stahl M, Stahl S, Stefkova S, Steinkamp O, Stenyakin O, Stevenson S, Stoica S, Stone S, Storaci B, Stracka S, Straticiuc M, Straumann U, Sun L, Sutcliffe W, Swientek K, Swientek S, Syropoulos V, Szczekowski M, Szumlak T, T'Jampens S, Tayduganov A, Tekampe T, Teklishyn M, Tellarini G, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Todd J, Tolk S, Tomassetti L, Tonelli D, Topp-Joergensen S, Torr N, Tournefier E, Tourneur S, Trabelsi K, Tran MT, Tresch M, Trisovic A, Tsaregorodtsev A, Tsopelas P, Tuning N, Ukleja A, Ustyuzhanin A, Uwer U, Vacca C, Vagnoni V, Valenti G, Vallier A, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Veneziano G, Vesterinen M, Viaud B, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Volkov V, Vollhardt A, Volyanskyy D, Voong D, Vorobyev A, Vorobyev V, Voß C, de Vries JA, Waldi R, Wallace C, Wallace R, Walsh J, Wandernoth S, Wang J, Ward DR, Watson NK, Websdale D, Weiden A, Whitehead M, Wilkinson G, Wilkinson M, Williams M, Williams MP, Williams M, Williams T, Wilson FF, Wimberley J, Wishahi J, Wislicki W, Witek M, Wormser G, Wotton SA, Wright S, Wyllie K, Xie Y, Xu Z, Yang Z, Yu J, Yuan X, Yushchenko O, Zangoli M, Zavertyaev M, Zhang L, Zhang Y, Zhelezov A, Zhokhov A, Zhong L, Zucchelli S. Evidence for the Strangeness-Changing Weak Decay Ξ_{b}^{-}→Λ_{b}^{0}π^{-}. PHYSICAL REVIEW LETTERS 2015; 115:241801. [PMID: 26705625 DOI: 10.1103/physrevlett.115.241801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2015] [Indexed: 06/05/2023]
Abstract
Using a pp collision data sample corresponding to an integrated luminosity of 3.0 fb^{-1}, collected by the LHCb detector, we present the first search for the strangeness-changing weak decay Ξ_{b}^{-}→Λ_{b}^{0}π^{-}. No b hadron decay of this type has been seen before. A signal for this decay, corresponding to a significance of 3.2 standard deviations, is reported. The relative rate is measured to be f_{Ξ_{b}^{-}}/f_{Λ_{b}^{0}}B(Ξ_{b}^{-}→Λ_{b}^{0}π^{-})=(5.7±1.8_{-0.9}^{+0.8})×10^{-4},where f_{Ξ_{b}^{-}} and f_{Λ_{b}^{0}} are the b→Ξ_{b}^{-} and b→Λ_{b}^{0} fragmentation fractions, and B(Ξ_{b}^{-}→Λ_{b}^{0}π^{-}) is the branching fraction. Assuming f_{Ξ_{b}^{-}}/f_{Λ_{b}^{0}} is bounded between 0.1 and 0.3, the branching fraction B(Ξ_{b}^{-}→Λ_{b}^{0}π^{-}) would lie in the range from (0.57±0.21)% to (0.19±0.07)%.
Collapse
|
471
|
Wang Y, Han X, Li YD, Zhao SY, Zhang DJ, Zhao ZH, Wang YB. Effects of tumor-specific antigen induced by lentinan on murine H22 hepatocellular carcinoma immunoprophylaxis. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2015; 19:4516-4524. [PMID: 26698247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE Hepatocellular carcinoma (HCC) is one of the most prevalent tumor types and the third most common form of morbidity in cancer-related deaths worldwide. Lentinan isolated from Lentinus edodes, is known to be a biologically active macromolecule with extremely strong activation of the human immune system such as host-mediated anti-cancer activity. The aim of this study is to investigate the immunoprophylaxis effect of the antigens induced by lentinan on murine hepatocellular carcinoma. MATERIALS AND METHODS The antigens were prepared by a co-culture method (HCL) and purified by ammonium sulfate fractionation precipitation (Z1, Z2, Z3). The effects of antigens on murine hepatocellular carcinoma immunoprophylaxis were determined in vivo. The cellular immunity of the immunized mice was tested by spleen lymphocyte proliferation tests and peritoneal macrophage phagocytosis assays. The tumor-specific antigen was confirmed by Western blot analysis. RESULTS Results in vivo revealed that the antigens (HCL/Z1) activated immunoprophylaxis against hepatocellular carcinoma with a better survival status. The survival rates (60%, 100%) of the HCL/Z1 group were better than the model group (p < 0.01). The quantity of lymphocytes in the spleen in the HCL or Z1 groups treated with ConA or LPS were higher than that of the model group (p < 0.01). The phagocytosis ability of macrophages in the HCL or Z1 groups was better than that of the control group or model group (p < 0.01). The characterization of Western blot analysis showed that about 59.6 kDa tumor specific antigen combined with antiserum of immunized mice specifically appeared in antigens. CONCLUSIONS The newly generated tumor-specific antigen played a key role in the anti-tumor immune response and in activating the immune system. Our results suggest that this protein could serve as a tumor vaccine, and it could generate new ideas for tumor immunoprophylaxis.
Collapse
|
472
|
Hennessy S, Leonard CE, Gagne JJ, Flory JH, Han X, Brensinger CM, Bilker WB. Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions. Clin Pharmacol Ther 2015; 99:92-100. [PMID: 26479278 DOI: 10.1002/cpt.277] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Revised: 10/01/2015] [Accepted: 10/14/2015] [Indexed: 12/13/2022]
Abstract
A drug-drug interaction (DDI) occurs when one or more drugs affect the pharmacokinetics (the body's effect on the drug) and/or pharmacodynamics (the drug's effect on the body) of one or more other drugs. Pharmacoepidemiologic studies are the principal way of studying the health effects of potential DDIs. This article discusses aspects of pharmacoepidemiologic research designs that are particularly salient to the design and interpretation of pharmacoepidemiologic studies of DDIs.
Collapse
|
473
|
Han X, Quinney SK, Wang Z, Zhang P, Duke J, Desta Z, Elmendorf JS, Flockhart DA, Li L. Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach. Clin Pharmacol Ther 2015; 98:321-7. [PMID: 25975815 PMCID: PMC4664558 DOI: 10.1002/cpt.150] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Revised: 11/11/2015] [Accepted: 05/12/2015] [Indexed: 01/29/2023]
Abstract
Myopathy is a group of muscle diseases that can be induced or exacerbated by drug–drug interactions (DDIs). We sought to identify clinically important myopathic DDIs and elucidate their underlying mechanisms. Five DDIs were found to increase the risk of myopathy based on analysis of observational data from the Indiana Network of Patient Care. Loratadine interacted with simvastatin (relative risk 95% confidence interval [CI] = [1.39, 2.06]), alprazolam (1.50, 2.31), ropinirole (2.06, 5.00), and omeprazole (1.15, 1.38). Promethazine interacted with tegaserod (1.94, 4.64). In vitro investigation showed that these DDIs were unlikely to result from inhibition of drug metabolism by CYP450 enzymes or from inhibition of hepatic uptake via the membrane transporter OATP1B1/1B3. However, we did observe in vitro synergistic myotoxicity of simvastatin and desloratadine, suggesting a role in loratadine–simvastatin interaction. This interaction was epidemiologically confirmed (odds ratio 95% CI = [2.02, 3.65]) using the data from the US Food and Drug Administration Adverse Event Reporting System.
Collapse
|
474
|
Han X, Tian Q, Chen F, Wang Y, Chen H. [Pulmonary ultrasound guidance of congenital heart disease postoperative ventilator applications]. ZHONGHUA YI XUE ZA ZHI 2015; 95:3347-3350. [PMID: 26812974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE To investigate the pulmonary ultrasound in children with congenital heart disease postoperative invasive ventilator time, non-invasive ventilator use the guide. METHODS Using prospective clinical observation research methods, Randomly divide 100 cases ranged from 6 months to 3 years old in cardiopulmonary bypass after congenital heart disease surgery patients into ultrasound group and control group, 50 cases in each group. All postoperative give positive cardiac function maintenance, diuresis, etc. Ultrasound group adopted the pulmonary ultrasound in children with pulmonary interstitial pulmonary edema monitoring and guide to extubation, enable the timing of the noninvasive ventilator support; Control group based on the bedside chest X-ray lung condition. Compare two groups of children with mechanical ventilation time (including the invasive and noninvasive ventilator support), noninvasive ventilator utilization rate and its accuracy, start the noninvasive ventilator time, the incidence of ventilator associated pneumonia (VAP), secondary tracheal intubation cases and ICU stay time, etc. RESULTS The ultrasound group compared with the control group in Invasive ventilator time [(15.0 ± 11.0) vs (20.0 ± 13.5, P=0.043)], noninvasive ventilation time [(38.5 ± 11.8) vs (48.6 ± 21.9, P=0.032)], the number of cases of the use of noninvasive ventilation (10 cases vs 22 cases, P=0.041), the correct use of the number of cases (10 vs 14, P=0.034) and VAP cases (3 vs 8, P=0.044), there was statistical significance, P< 0.05. The ultrasound group of children with ICU stay time was significantly lower than the control group [(66.0 ± 38.9) vs (82.0 ± 42.4, P=0.038)]; Control group had 2 cases with secondary tracheal intubation, ultrasound group one, comparing the two groups has no statistical significance (P> 0.05). CONCLUSION Postoperative children with congenital heart disease using pulmonary ultrasound evaluation of pulmonary interstitial edema,guide the ventilator, it can effectively shorten (invasive and noninvasive mechanical ventilation time and ICU length of hospital stay, lung ultrasound has instant, noninvasive, No radiation, repeatable,pulmonary ultrasound will be important after cardiopulmonary bypass interstitial lung edema diagnosis, evaluation of treatment means and helps to treat critically ill children.
Collapse
|
475
|
Zhang L, Liu G, Han X, Liu J, Li GX, Zou DW, Li ZS. Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis. Neurogastroenterol Motil 2015; 27:1648-56. [PMID: 26353842 DOI: 10.1111/nmo.12664] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2015] [Accepted: 07/31/2015] [Indexed: 12/13/2022]
Abstract
BACKGROUND Reflux esophagitis (RE) is one of the common gastrointestinal diseases that are increasingly recognized as a significant health problem. This study was designed to investigate the role of p38 mitogen-activated protein kinase (MAPK) in experimental chronic RE model of rats. METHODS Chronic acid RE rats were induced by fundus ligation and partial obstruction of the pylorus and treated with SB203580 (a p38 MAPK inhibitor, i.p., 1 mg/kg/day) for 14 days. KEY RESULTS Immunohistochemical staining and Western blotting results revealed the activation of p38 MAPK signaling in the esophagus mucosa 14 days post injury. Through gross and histological assessment, we found that inhibition of p38 MAPK activation by SB203580 attenuated esophageal mucosal damage in RE rats. Inhibition of p38 MAPK activation in RE rats attenuated esophageal barrier dysfunction, through enhancing the expression of tight junction proteins and reducing the expression of matrix matalloproteinases-3 and -9. Inhibition of p38 MAPK activation in RE rats reduced CD68-positive cells in esophagus mucosa and mRNA levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in esophagus and protein levels of TNF-α, IL-6, and IL-1β in serum. In addition, we found that inhibition of p38 MAPK activation in RE rats suppressed protein expression of inducible nitric oxide synthase and reduced formation of nitric oxide (NO), 3-nitrotyrosin, and malondialdehyde in esophagus. CONCLUSIONS & INFERENCES Inhibition of p38 MAPK activation attenuated esophageal mucosal damage in acid RE rats, possibly by modulating esophageal barrier function and regulating inflammatory cell recruitment, and the subsequent formation of cytokines, NO, and reactive oxygen species.
Collapse
|